0001333277-21-000025.txt : 20210128 0001333277-21-000025.hdr.sgml : 20210128 20210128150052 ACCESSION NUMBER: 0001333277-21-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210126 FILED AS OF DATE: 20210128 DATE AS OF CHANGE: 20210128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TRUEX PAUL F CENTRAL INDEX KEY: 0001120362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 21564446 MAIL ADDRESS: STREET 1: PENINSULA PHARMACEUTICALS, INC. STREET 2: 1751 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-01-26 0001042074 CymaBay Therapeutics, Inc. CBAY 0001120362 TRUEX PAUL F C/O CYMABAY THERAPEUTICS, INC. 7575 GATEWAY BOULEVARD, SUITE 110 NEWARK CA 94560 1 0 0 0 Stock Option (right to buy) 5.78 2021-01-26 4 A 0 32000 0 A 2031-01-25 Common Stock 32000 32000 D The option vests as to 1/12 of the underlying shares monthly from January 1, 2021. /s/ Sujal Shah, as attorney-in-fact for Paul Truex 2021-01-27